Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Rascol

Showing results (51-60 of 220) with videos related to

Pageof 22
Sort By:
Neuroscience and Biobehavioral Reviews|July 1, 1997
Glutamate antagonists and Parkinson's disease: a review of clinical dataJ L Montastruc, O Rascol, J M Senard
Parkinsonism & Related Disorders|September 10, 2002
The management of patients with early Parkinson's diseaseO Rascol, P Payoux, J Ferreira, et al.
Clinical Neuropharmacology|June 1, 1990
Migraine attacks induced by subcutaneous apomorphine in two migrainous parkinsonian patientsU Sabatini, O Rascol, A Rascol, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's diseaseJ L Montastruc, M Ziegler, O Rascol, et al.
European Neurology|January 1, 1995
Treatment of hemifacial spasm with botulinum toxin. Value of preinjection electromyography abnormalities for predicting postinjection lower facial paresisG Angibaud, M S Moreau, O Rascol, et al.
Advances in Neurology|May 12, 2001
The pharmacologic treatment of gait ignition failureO Rascol, N Fabre, C Brefel-Courbon, et al.
Lancet (London, England)|August 25, 1990
Apomorphine test in parkinsonian syndromesO Rascol, J M Senard, A Rascol, et al.
Fundamental & Clinical Pharmacology|January 1, 1993
Lack of yohimbine effect on ambulatory blood pressure recording: a double-blind cross-over trial in parkinsonians with orthostatic hypotensionJ M Senard, O Rascol, A Rascol, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1992
A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's diseaseJ L Montastruc, O Rascol, J M Senard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1994
A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow upJ L Montastruc, O Rascol, J M Senard, et al.
Pageof 22

Showing results (51-60 of 220) with videos related to

Sort By:
Pageof 22
Neuroscience and Biobehavioral Reviews|July 1, 1997
Glutamate antagonists and Parkinson's disease: a review of clinical dataJ L Montastruc, O Rascol, J M Senard
Parkinsonism & Related Disorders|September 10, 2002
The management of patients with early Parkinson's diseaseO Rascol, P Payoux, J Ferreira, et al.
Clinical Neuropharmacology|June 1, 1990
Migraine attacks induced by subcutaneous apomorphine in two migrainous parkinsonian patientsU Sabatini, O Rascol, A Rascol, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's diseaseJ L Montastruc, M Ziegler, O Rascol, et al.
European Neurology|January 1, 1995
Treatment of hemifacial spasm with botulinum toxin. Value of preinjection electromyography abnormalities for predicting postinjection lower facial paresisG Angibaud, M S Moreau, O Rascol, et al.
Advances in Neurology|May 12, 2001
The pharmacologic treatment of gait ignition failureO Rascol, N Fabre, C Brefel-Courbon, et al.
Lancet (London, England)|August 25, 1990
Apomorphine test in parkinsonian syndromesO Rascol, J M Senard, A Rascol, et al.
Fundamental & Clinical Pharmacology|January 1, 1993
Lack of yohimbine effect on ambulatory blood pressure recording: a double-blind cross-over trial in parkinsonians with orthostatic hypotensionJ M Senard, O Rascol, A Rascol, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1992
A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's diseaseJ L Montastruc, O Rascol, J M Senard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1994
A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow upJ L Montastruc, O Rascol, J M Senard, et al.
Pageof 22